Skip to content

Machine learning algorithms for predicting arrhythmic events in Hypertrophic Cardiomyopathy: limited enhancement beyond late gadolinium enhancement.

Jul 2026 · The International Journal of Cardiovascular Imaging · 1 citation · 40 references
Medicine

TL;DR

A ML model using available clinical variables significantly outperformed the ESC HCM risk score in predicting arrhythmic events in HCM and its incremental value over LGE alone was weak, underscoring the strong predictive value of this imaging marker.

View source

Similar papers

Open access Sep 2026

Prognostic significance of artificial intelligence-quantified late gadolinium enhancement on cardiac magnetic resonance in hypertrophic cardiomyopathy

Artificial intelligence-based quantitative assessment of LGE is an independent predictor of adverse cardiovascular outcomes in patients with HCM and may represent a clinically meaningful imaging biomarker for risk stratification.

Youngsang Jeong, Jong-Il Park, Kang-Un Choi et al. · 0 citations
Open access Aug 2026

Enhancing risk prediction for sudden cardiac death: quantitative late gadolinium enhancement analysis in hypertrophic cardiomyopathy

Both single- and dual-threshold LGE quantification independently predict SCD in patients with HCM, while dual-threshold gray zone metrics demonstrate stronger prognostic associations, underscore the importance of standardizing LGE quantification to improve SCD risk stratification in patients with HCM.

Li-Li Wang, Hongbo Zhang, Guan-Yu Lu et al. · 0 citations
Aug 2026

Left Atrial Reservoir Strain Improves Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy.

LARS was an independent predictor of SCD-related events and effectively stratified risk among patients classified as low-to-intermediate risk by the HCM Risk-SCD score and adding LARS to the HCM Risk-SCD score significantly improved risk discrimination in the low-to-intermediate risk population.

S. Kwak, Younghyun Kang, Ji-Hyun Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.